Standard versus Newer Antibacterial Agents in the Treatment of Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Trial of Trimethoprim‐Sulfamethoxazole versus Ciprofloxacin-Reference-Cited by-同舟云学术

Standard versus Newer Antibacterial Agents in the Treatment of Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Trial of Trimethoprim‐Sulfamethoxazole versus Ciprofloxacin

Published:2010-07-15 Issue:2 Volume:51 Page:143-149
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Nouira Semir,Marghli Soudani,Besbes Lamia,Boukef Riadh,Daami Monia,Nciri Noureddine,Elatrous Souheil,Abroug Fekri

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/51/2/143/854668/51-2-143.pdf

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimethoprim-Based multicomponent solid Systems: Mechanochemical Screening, characterization and antibacterial activity assessment;International Journal of Pharmaceutics;2024-08

2. Randomized Controlled Trials on Chronic Obstructive Pulmonary Disease in Africa: A Systematic Review;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2023

3. Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study;Biomedicines;2021-12-05

4. Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?;Archivos de Bronconeumología;2021-12

5. Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations;Seminars in Respiratory and Critical Care Medicine;2020-08-11